Header cover image

U.S. Biotech Industry Analysis

UpdatedMay 26, 2022
DataAggregated Company Financials
Companies637
  • 7D0.4%
  • 3M-7.0%
  • 1Y-22.1%
  • YTD-22.1%

Last week, the Biotech industry hasn't moved much but Amgen is up 3.4% in that time. As for the longer term, the industry has declined 22% in the last year. Earnings are forecast to grow by 10% annually.

Industry Valuation and Performance

Has the U.S. Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Fri, 27 May 2022US$1.0tUS$212.6bUS$11.1b15.4x
Sun, 24 Apr 2022US$1.2tUS$226.6bUS$14.7b17.8x
Tue, 22 Mar 2022US$1.3tUS$221.9bUS$10.6b19.5x
Thu, 17 Feb 2022US$1.3tUS$216.3bUS$5.9b22.3x
Sat, 15 Jan 2022US$1.3tUS$212.1bUS$2.7b24.4x
Mon, 13 Dec 2021US$1.4tUS$212.0bUS$3.2b25x
Wed, 10 Nov 2021US$1.5tUS$204.7bUS$843.8m26.3x
Fri, 08 Oct 2021US$1.5tUS$196.3b-US$2,599,455,696.0023.7x
Sun, 05 Sep 2021US$1.6tUS$197.0b-US$1,737,879,785.5822.4x
Tue, 03 Aug 2021US$1.5tUS$197.0b-US$1,424,156,187.5824.2x
Fri, 07 May 2021US$1.4tUS$174.8b-US$11,096,405,382.5522.2x
Mon, 08 Feb 2021US$1.4tUS$162.7b-US$10,894,429,089.9019x
Sun, 01 Nov 2020US$1.1tUS$150.4b-US$4,980,288,109.8820.1x
Wed, 05 Aug 2020US$1.1tUS$138.5b-US$5,301,501,654.2921.5x
Sat, 09 May 2020US$833.4bUS$100.1b-US$4,725,714,793.4218.3x
Fri, 31 Jan 2020US$732.3bUS$98.3b-US$758,235,190.9714.5x
Mon, 04 Nov 2019US$667.9bUS$96.7b-US$2,697,818,944.899.3x
Thu, 08 Aug 2019US$648.8bUS$94.3bUS$1.3b15.1x
Median PE Ratio

13.4x


Total Market Cap: US$604.5bTotal Earnings: US$2.6bTotal Revenue: US$93.1bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Biotech Industry Median PE3Y Average 18.8x202020212022
Current Industry PE
  • Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 18.8x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have grown 62% per year over the last three years.
  • Revenues for these companies have grown 32% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Biotech compare with similar industries?

US Market1.04%
Healthcare1.30%
Biotech0.45%
Biotech0.45%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AMGN AmgenUS$253.053.4%
+US$4.4b
7.5%PS23.6x
VRTX Vertex PharmaceuticalsUS$269.655.6%
+US$3.6b
30.1%PS28.1x
REGN Regeneron PharmaceuticalsUS$683.444.0%
+US$2.8b
38.0%PS9.3x
UTHR United TherapeuticsUS$224.7820.6%
+US$1.7b
21.0%PS14.8x
BIIB BiogenUS$204.225.8%
+US$1.6b
-23.6%PS20.6x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BNTX

US$158.15

BioNTech

7D

-5.8%

1Y

-20.0%

MRNA

US$135.80

Moderna

7D

-5.3%

1Y

-24.4%

BIIB

US$204.22

Biogen

7D

5.8%

1Y

-23.6%